Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 28 of Lantern Pharma Inc.'s SEC filings and found 6 warrant series, 1 ATM program, 1 shelf registration, 1 S-1 registration and 2 completed offerings on file for LTRN. The latest dilution event on file is an offering on Sep 30, 2026. Analysis updated Oct 13, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CURXCuranex Pharmaceuticals Inc Common Stock
BCLIBrainstorm Cell Therapeutics Inc.
BLRXBioLineRX Ltd
PTNPalatin Technologies, Inc.
MBRXMoleculin Biotech, Inc.
INABIN8bio, Inc.
CMMBChemomab Therapeutics Ltd. American Depositary Share
CALCCalciMedica, Inc.
LEXXLexaria Bioscience Corp.
TOVXTheriva Biologics, Inc.
GDTCCytoMed Therapeutics Limited Ordinary Shares
INTIInhibitor Therapeutics, Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
TPSTTempest Therapeutics, Inc.
PHIOPhio Pharmaceuticals Corp.